← Back to Search

Procedure

Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches

N/A
Waitlist Available
Led By Wade Gofton, MD, FRCSC
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this is from baseline (can be measured anytime to a maximum of one month before surgery) to 12 months post-operatively.
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing the outcomes of two different approaches to hip replacement - the Direct Anterior Approach (DAA) and the Supercapsular Percutaneously Assisted Total Hip (SuperPATH) approach. Both approaches replace hips without cutting any muscles. DAA has been used for many years, but it has a high learning curve and can be difficult for doctors to use. SuperPATH is a newer technique which has been shown in studies to be adopted with less complications even during the learning phase.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this is from baseline (can be measured anytime to a maximum of one month before surgery) to 12 months post-operatively.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this is from baseline (can be measured anytime to a maximum of one month before surgery) to 12 months post-operatively. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline in Hip disability and Osteoarthritis Outcome Score (HOOS) activities of daily living (ADL)
Change in Gait analysis
Secondary study objectives
Change in Complication rates
Change in EQ-5D-5L
Change in Pre-post Hgb
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SuperPATHExperimental Treatment1 Intervention
SuperPATH approach surgery to replace the hip.
Group II: Direct Anterior Approach (DAA)Active Control1 Intervention
Direct Anterior Approach surgery to replace the hip.

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
576 Previous Clinical Trials
3,139,828 Total Patients Enrolled
MicroPort Orthopedics Inc.Industry Sponsor
31 Previous Clinical Trials
3,386 Total Patients Enrolled
Wade Gofton, MD, FRCSCPrincipal InvestigatorThe Ottawa Hospital
1 Previous Clinical Trials
160 Total Patients Enrolled
~16 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top